BMPs （Bone Morphogenetic Proteins） belong to the TGF-β superfamily of structurally related signaling proteins.
BMP-2 is a potent osteoinductive cytokine, capable of inducing bone and cartilage formation in association with osteoconductive carriers such as collagen and synthetic hydroxyapatite.
In addition to its osteogenic activity, BMP-2 plays an important role in cardiac morphogenesis, and is expressed in a variety of tissues, including lung, spleen, brain, liver, prostate ovary and small intestine.
The functional form of BMP-2 is a 26 kDa protein composed of two identical 114 amino acid polypeptide chains linked by a single disulfide bond.
Each BMP-2 monomer is expressed as the C-terminal part of a precursor polypeptide, which also contains a 23 amino acid signal sequence for secretion, and a 259 amino acid propeptide.
After dimerization of this precursor, the covalent bonds between the propeptide （which is also a disulfide-linked homodimer） and the mature BMP-2 ligand are cleaved by a furin-type protease.
The BioGems Human BMP-2 Pre-Coated ELISA （Enzyme-Linked Immunosorbent Assay） kit is a solid phase immunoassay specially designed to measure BMP-2 with a 96-well strip plate that is pre-coated with mouse monoclonal antibody specific for BMP-2.
It contains CHO-expressed recombinant BMP-2.
The detection antibody is a biotinylated goat polyclonal antibody specific for BMP-2.
The kit is analytically validated with ready to use reagents.
